logo

For the Inventor, By the Inventor

Hamilton, Bermuda

Abbott Biotechnology Ltd.


USPTO Granted Patents = 17

% Expired Patents = 52.9



Trademarks = 2

Forward Citations = 1,771

Loading Chart...
Loading Chart...

33 inventors (with patents filed for the assignee):

goldMedal Boris Labkovsky (8 out of 34 patents)

silverMedal Zehra Kaymakcalan (8 out of 32 patents)

bronzeMedal Jochen G Salfeld (8 out of 33 patents)

4.  Michael White (8 out of 25 patents)

5.  Paul Sakorafas (8 out of 18 patents)

6.  Deborah J Allen (8 out of 13 patents)

7.  John A Mankovich (8 out of 17 patents)

8.  Andrew J Roberts (8 out of 12 patents)

9.  David Schoenhaut (8 out of 14 patents)

10.  Tristan J Vaughan (8 out of 33 patents)

11.  Brian Timothy McGuinness (8 out of 24 patents)

12.  Alison Jane Wilton (7 out of 20 patents)

13.  Hendricus R J M Hoogenboom (7 out of 13 patents)

14.  Joseph F Julian (4 out of 32 patents)

15.  Min M Wan (2 out of 13 patents)


17 patents:

1. 8414894 - Human antibodies that bind human TNFα and methods of using same (2013-04-09),
2. 8372401 - Human antibodies that bind human TNFα (2013-02-12),
3. 8372400 - Methods of treating disorders using human antibodies that bind human TNFα (2013-02-12),
4. 8231876 - Purified antibody composition (2012-07-31),
5. 8216583 - Formulation of human antibodies for treating TNF-α associated disorders (2012-07-10),
6. 8206714 - Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa (2012-06-26),
7. 8197813 - Human antibodies that bind human TNFα (2012-06-12),
8. 8162887 - Automatic injection devices (2012-04-24),
9. 8034906 - Crystalline anti-hTNFalpha antibodies (2011-10-11),
10. 7938802 - Automatic injection devices (2011-05-10),
11. 7919264 - Methods and compositions for determining the efficacy of a treatment for ankylosing spondylitis using biomarkers (2011-04-05),
12. 7863426 - Antibody purification (2011-01-04),
13. D629509 - Automatic injection device (2010-12-21),
14. D622374 - Automatic injection device (2010-08-24),
15. 7588761 - Human antibodies that bind human TNFα (2009-09-15),
Company Overview
Abbott Biotechnology Ltd., based in Hamilton, specializes in the development and manufacturing of innovative biopharmaceuticals and medical devices. The company focuses on advancing healthcare solutions through cutting-edge research in areas such as diagnostics, nutrition, and cardiovascular health. With a commitment to improving patient outcomes, Abbott leverages its expertise in biotechnology to create products that address complex medical needs, contributing to the global healthcare landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

17 Patents

#32 in Hamilton

#37 in Bermuda

#35,918 in the World

Hamilton, BM
Hamilton, Bermuda

Abbott Biotechnology Ltd.

Forward Citations = 1,771

33 inventors:

goldMedal Boris Labkovsky (8 out of 34 patents)

silverMedal Zehra Kaymakcalan (8 out of 32 patents)

bronzeMedal Jochen G Salfeld (8 out of 33 patents)

4.  Michael White (8 out of 25 patents)

5.  Paul Sakorafas (8 out of 18 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abbott Biotechnology Ltd.. Retrieved from https://idiyas.com/company/abbott-biotechnology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…